<?xml version="1.0" encoding="UTF-8"?>
<ref id="B32-life-11-00214">
 <label>32.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Thompson</surname>
    <given-names>M.D.</given-names>
   </name>
   <name>
    <surname>Sakurai</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Rainero</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Maj</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Kukkonen</surname>
    <given-names>J.P.</given-names>
   </name>
  </person-group>
  <article-title>Orexin receptor multimerization versus functional interactions: Neuropharmacological implications for opioid and cannabinoid signalling and pharmacogenetics</article-title>
  <source>Pharmaceuticals</source>
  <year>2017</year>
  <volume>10</volume>
  <elocation-id>79</elocation-id>
  <pub-id pub-id-type="doi">10.3390/ph10040079</pub-id>
  <?supplied-pmid 28991183?>
  <pub-id pub-id-type="pmid">28991183</pub-id>
 </element-citation>
</ref>
